These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


149 related items for PubMed ID: 17105925

  • 1. Fluoxetine as a potential pharmacotherapy for methamphetamine dependence: studies in mice.
    Takamatsu Y, Yamamoto H, Ogai Y, Hagino Y, Markou A, Ikeda K.
    Ann N Y Acad Sci; 2006 Aug; 1074():295-302. PubMed ID: 17105925
    [Abstract] [Full Text] [Related]

  • 2. The Selective Serotonin Reuptake Inhibitor Paroxetine, but not Fluvoxamine, Decreases Methamphetamine Conditioned Place Preference in Mice.
    Takamatsu Y, Yamamoto H, Hagino Y, Markou A, Ikeda K.
    Curr Neuropharmacol; 2011 Mar; 9(1):68-72. PubMed ID: 21886565
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of donepezil on methamphetamine and cocaine dependencies.
    Takamatsu Y, Yamanishi Y, Hagino Y, Yamamoto H, Ikeda K.
    Ann N Y Acad Sci; 2006 Aug; 1074():418-26. PubMed ID: 17105940
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment.
    Igari M, Shen HW, Hagino Y, Fukushima S, Kasahara Y, Lesch KP, Murphy DL, Hall FS, Uhl GR, Ikeda K, Yaegashi N, Sora I.
    Behav Pharmacol; 2015 Feb; 26(1-2):167-79. PubMed ID: 25485646
    [Abstract] [Full Text] [Related]

  • 6. Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction.
    Itzhak Y, Ali SF.
    Ann N Y Acad Sci; 2002 Jun; 965():127-35. PubMed ID: 12105090
    [Abstract] [Full Text] [Related]

  • 7. Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1.
    Achat-Mendes C, Lynch LJ, Sullivan KA, Vallender EJ, Miller GM.
    Pharmacol Biochem Behav; 2012 Apr; 101(2):201-7. PubMed ID: 22079347
    [Abstract] [Full Text] [Related]

  • 8. Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice.
    Gou H, Wen D, Ma C, Li M, Li Y, Zhang W, Liu L, Cong B.
    Behav Brain Res; 2015 Apr 15; 283():87-96. PubMed ID: 25629941
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.
    Baumann MH, Phillips JM, Ayestas MA, Ali SF, Rice KC, Rothman RB.
    Ann N Y Acad Sci; 2002 Jun 15; 965():92-108. PubMed ID: 12105088
    [Abstract] [Full Text] [Related]

  • 11. Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters.
    Numachi Y, Ohara A, Yamashita M, Fukushima S, Kobayashi H, Hata H, Watanabe H, Hall FS, Lesch KP, Murphy DL, Uhl GR, Sora I.
    Eur J Pharmacol; 2007 Oct 31; 572(2-3):120-8. PubMed ID: 17673199
    [Abstract] [Full Text] [Related]

  • 12. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
    Achat-Mendes C, Anderson KL, Itzhak Y.
    Neuropsychopharmacology; 2007 Mar 31; 32(3):531-41. PubMed ID: 16760923
    [Abstract] [Full Text] [Related]

  • 13. The circadian gene, Per2, influences methamphetamine sensitization and reward through the dopaminergic system in the striatum of mice.
    Kim M, Custodio RJ, Botanas CJ, de la Peña JB, Sayson LV, Abiero A, Ryoo ZY, Cheong JH, Kim HJ.
    Addict Biol; 2019 Sep 31; 24(5):946-957. PubMed ID: 30091820
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms.
    Calpe-López C, García-Pardo MP, Aguilar MA.
    Molecules; 2019 Jul 16; 24(14):. PubMed ID: 31315244
    [Abstract] [Full Text] [Related]

  • 18. Inhibiting effects of rhynchophylline on zebrafish methamphetamine dependence are associated with amelioration of neurotransmitters content and down-regulation of TH and NR2B expression.
    Jiang M, Chen Y, Li C, Peng Q, Fang M, Liu W, Kang Q, Lin Y, Yung KK, Mo Z.
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jul 04; 68():31-43. PubMed ID: 27009763
    [Abstract] [Full Text] [Related]

  • 19. Selective serotonin reuptake inhibitors, fluoxetine and paroxetine, attenuate the expression of the established behavioral sensitization induced by methamphetamine.
    Kaneko Y, Kashiwa A, Ito T, Ishii S, Umino A, Nishikawa T.
    Neuropsychopharmacology; 2007 Mar 04; 32(3):658-64. PubMed ID: 16738540
    [Abstract] [Full Text] [Related]

  • 20. Methamphetamine reward in mice as assessed by conditioned place preference test with Supermex sensors: effect of subchronic clorgyline pretreatment.
    Kitanaka N, Kitanaka J, Tatsuta T, Watabe K, Morita Y, Takemura M.
    Neurochem Res; 2006 Jun 04; 31(6):805-13. PubMed ID: 16791472
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.